Literature DB >> 19022977

Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue.

Erica L Unger1, Jason A Wiesinger, Lei Hao, John L Beard.   

Abstract

Iron deficiency anemia in early life alters the development and functioning of the dopamine neurotransmitter system, but data regarding the specific effects of brain iron loss on dopamine D(2) receptor regulation are lacking. Cell culture and animal models were employed in this study to determine whether D(2) receptor expression is altered when cellular iron levels are depleted. Endogenous D(2) receptor-expressing PC12 cells exposed to increasing concentrations of the iron chelator desferrioxamine (25-100 micromol/L) exhibited dose-dependent decreases in total D(2) receptor protein concentrations (20-65%), but there were minimal effects on D(2) receptor mRNA levels. When iron-deficient cells were repleted with ferric ammonium citrate for 24 h, D(2) receptor protein densities were similar to control. Dietary iron deficiency for 6 wk in weanling rats also reduced regional iron concentrations by nearly 50% in the ventral midbrain and caudate but did not affect D(2) receptor mRNA levels in the ventral midbrain. Iron deficiency significantly reduced membrane D(2) receptor protein levels by >70% in caudate, whereas cytosolic concentrations showed only 25% losses. D(2) receptor protein densities and regional iron concentrations were restored within 2 wk of dietary iron repletion. These results support the concept that D(2) receptor gene expression is not significantly changed by iron deficiency, whereas dopamine receptor trafficking is affected and is likely related to known dopamine system alterations in iron deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19022977      PMCID: PMC3415866          DOI: 10.3945/jn.108.095224

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  45 in total

1.  Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients.

Authors: 
Journal:  Sleep Med       Date:  2001-01       Impact factor: 3.492

2.  Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression.

Authors:  I G Ruiz; P de la Torre; T Diaz; E Esteban; J D Morillas; T Muñoz-Yagüe; J A Solís-Herruzo
Journal:  DNA Cell Biol       Date:  2000-03       Impact factor: 3.311

3.  Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.

Authors:  Jason A Wiesinger; James P Buwen; Christopher J Cifelli; Erica L Unger; Byron C Jones; John L Beard
Journal:  J Neurochem       Date:  2007-01       Impact factor: 5.372

4.  Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats.

Authors:  K M Erikson; D J Pinero; J R Connor; J L Beard
Journal:  J Nutr       Date:  1997-10       Impact factor: 4.798

5.  Iron deficiency alters dopamine transporter functioning in rat striatum.

Authors:  K M Erikson; B C Jones; J L Beard
Journal:  J Nutr       Date:  2000-11       Impact factor: 4.798

6.  Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.

Authors:  C Brodeur; J Montplaisir; R Godbout; R Marinier
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

7.  Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C.

Authors:  Manuel Miranda; Christine C Wu; Tatiana Sorkina; Davin R Korstjens; Alexander Sorkin
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

Review 8.  Iron deficiency alters brain development and functioning.

Authors:  John Beard
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

9.  L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

Authors:  C Trenkwalder; K Stiasny; T Pollmächer; T Wetter; J Schwarz; R Kohnen; J Kazenwadel; H P Krüger; S Ramm; M Künzel
Journal:  Sleep       Date:  1995-10       Impact factor: 5.849

10.  Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain.

Authors:  S L Clardy; X Wang; W Zhao; W Liu; G A Chase; J L Beard; B True Felt; J R Connor
Journal:  J Neural Transm Suppl       Date:  2006
View more
  22 in total

Review 1.  Neural circuitry and mechanisms of waiting impulsivity: relevance to addiction.

Authors:  Jeffrey W Dalley; Karen D Ersche
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

2.  Maternal and child mental health: role of nutrition. Introduction.

Authors:  Maureen M Black; Usha Ramakrishnan
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

3.  Responses of HSC70 expression in diencephalon to iron deficiency anemia in rats.

Authors:  Fuminori Kawano; Yoshihiko Oke; Sachiko Nomura; Ryo Fujita; Takashi Ohira; Naoya Nakai; Yoshinobu Ohira
Journal:  J Physiol Sci       Date:  2011-08-03       Impact factor: 2.781

4.  Behavior and monoamine deficits in prenatal and perinatal iron deficiency are not corrected by early postnatal moderate-iron or high-iron diets in rats.

Authors:  Erica L Unger; Amy R Hurst; Michael K Georgieff; Tim Schallert; Raghavendra Rao; James R Connor; Niko Kaciroti; Betsy Lozoff; Barbara Felt
Journal:  J Nutr       Date:  2012-09-18       Impact factor: 4.798

5.  Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission.

Authors:  César Quiroz; Virginia Pearson; Seema Gulyani; Richard Allen; Christopher Earley; Sergi Ferré
Journal:  Exp Neurol       Date:  2010-04-10       Impact factor: 5.330

6.  Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.

Authors:  César Quiroz; Seema Gulyani; Wan Ruiqian; Jordi Bonaventura; Roy Cutler; Virginia Pearson; Richard P Allen; Christopher J Earley; Mark P Mattson; Sergi Ferré
Journal:  Neuropharmacology       Date:  2016-09-04       Impact factor: 5.250

7.  Influence of prenatal iron deficiency and MAOA genotype on response to social challenge in rhesus monkey infants.

Authors:  M S Golub; C E Hogrefe; E L Unger
Journal:  Genes Brain Behav       Date:  2012-03-13       Impact factor: 3.449

8.  In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study.

Authors:  Yumi Oboshi; Yasuomi Ouchi; Shunsuke Yagi; Satoshi Kono; Noriyoshi Nakai; Etsuji Yoshikawa; Masami Futatsubashi; Tatsuhiro Terada; Kang Kim; Kiyoshi Harada
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-11       Impact factor: 6.200

9.  Low brain iron effects and reversibility on striatal dopamine dynamics.

Authors:  Erica L Unger; Laura E Bianco; Byron C Jones; Richard P Allen; Christopher J Earley
Journal:  Exp Neurol       Date:  2014-07-03       Impact factor: 5.330

10.  Iron status in children with autism spectrum disorder.

Authors:  Ann Reynolds; Nancy F Krebs; Patricia A Stewart; Harriet Austin; Susan L Johnson; Nikki Withrow; Cynthia Molloy; S Jill James; Cynthia Johnson; Traci Clemons; Brianne Schmidt; Susan L Hyman
Journal:  Pediatrics       Date:  2012-11       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.